top of page


Treating non-small cell lung cancer with Geftinat 250mg Tablet
The medicine treats NSCLC with a specific mutation known as EGFR. Therefore, patients depend on using the Geftinat 250mg Tablet to treat this condition. It works by blocking abnormal proteins that help cancer grow and divide. This can decrease the cancer progression and spread inside the body. What is the Geftinat 250mg Tablet? This is an oral anticancer medication that belongs to the drug class known as tyrosine kinase inhibitors. Furthermore, it works by blocking specific p
magicine18
6 days ago2 min read


How Does Targeted Therapy Change the Treatment of EGFR-Mutated NSCLC?
The management of lung cancer now is not determined solely by the origin or stage of progression
magicine18
Aug 273 min read
bottom of page